Patents by Inventor Chang Gon Lee

Chang Gon Lee has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 1,3,4-oxadiazole derivative compounds as histone deacetylase 6 inhibitor, and the pharmaceutical composition comprising the same
    Patent number: 10717716
    Abstract: The present invention relates to novel compounds having histone deacetylase 6 (HDAC6) in-hibitory activity, stereoisomers thereof or pharmaceutically acceptable salts thereof the use thereof for the preparation of therapeutic medicaments, pharmaceutical compositions containing the same, a method for treating diseases using the composition, and methods for preparing the novel compounds.
    Type: Grant
    Filed: August 4, 2016
    Date of Patent: July 21, 2020
    Assignee: Chong Kun Dang Pharmaceutical Corp.
    Inventors: Jaekwang Lee, Yuntae Kim, Chang Sik Lee, Hyeseung Song, Dal-Yong Gwak, Jaeyoung Lee, Jung Taek Oh, Chang Gon Lee, Il Hyang Kim
  • 1,3,4-OXADIAZOLE DERIVATIVE COMPOUNDS AS HISTONE DEACETYLASE 6 INHIBITOR, AND THE PHARMACEUTICALCOMPOSITION COMPRISING THE SAME
    Publication number: 20180230114
    Abstract: The present invention relates to novel compounds having histone deacetylase 6 (HDAC6) in-hibitory activity, stereoisomers thereof or pharmaceutically acceptable salts thereof the use thereof for the preparation of therapeutic medicaments, pharmaceutical compositions containing the same, a method for treating diseases using the composition, and methods for preparing the novel compounds.
    Type: Application
    Filed: August 4, 2016
    Publication date: August 16, 2018
    Inventors: Jaekwang Lee, Yuntae Kim, Chang Sik Lee, Hyeseung Song, Dal-Yong Gwak, Jaeyoung Lee, Jung Taek Oh, Chang Gon Lee, Il Hyang Kim
  • Amide derivative for inhibiting the growth of cancer cells
    Patent number: 8188102
    Abstract: The present invention provides a novel amide derivative of formula (I) and a pharmaceutically acceptable salt thereof, and a pharmaceutical composition comprising same as an active ingredient.
    Type: Grant
    Filed: June 5, 2008
    Date of Patent: May 29, 2012
    Assignee: Hanmi Holdings Co., Ltd.
    Inventors: Kwang-Ok Lee, Mi Young Cha, Mi Ra Kim, Young Hee Jung, Chang Gon Lee, Se Young Kim, Keukchan Bang, Bum Woo Park, Bo Im Choi, Yun Jung Chae, Mi Young Ko, Han Kyong Kim, Young-Gil Ahn, Maeng Sup Kim, Gwan Sun Lee
  • NOVEL AMIDE DERIVATIVE FOR INHIBITING THE GROWTH OF CANCER CELLS
    Publication number: 20100179120
    Abstract: The present invention provides a novel amide derivative and a pharmaceutically acceptable salt thereof which selectively and effectively inhibits the growth of cancer cells induced by the overexpression of an epidermal growth factor receptor and also prevents the development of drug resistance caused by the mutation of EGFR tyrosine kinase, and a pharmaceutical composition comprising same as an active ingredient.
    Type: Application
    Filed: June 5, 2008
    Publication date: July 15, 2010
    Applicant: HANMI PHARM. CO., LTD.
    Inventors: Kwang-Ok Lee, Mi Young Cha, Mi Ra Kim, Young Hee Jung, Chang Gon Lee, Se Young Kim, Keukchan Bang, Bum Woo Park, Bo Im Choi, Yun Jung Chae, Mi Young Ko, Han Kyong Kim, Young-Gil Ahn, Maeng Sup Kim, Gwan Sun Lee
  • Office chair
    Patent number: D1114511
    Type: Grant
    Filed: July 7, 2023
    Date of Patent: February 24, 2026
    Assignee: PATRA CO., LTD.
    Inventor: Chang Gon Lee